SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-020316
Filing Date
2019-04-18
Accepted
2019-04-18 17:58:22
Documents
1
Period of Report
2019-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv519201_4.html 4  
1 OWNERSHIP DOCUMENT tv519201_4.xml 4 3917
  Complete submission text file 0001144204-19-020316.txt   5649
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address
Silverstein Christine Berni (Reporting) CIK: 0001772546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 19756796